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Abstract
The newly synthesized 11-cis-7-methylretinal can form an artiWcial visual pigment with kinetic and spectroscopic properties similar to
the native pigment in the dark-state. However, its photobleaching behavior is altered, showing a Meta I-like photoproduct. This behavior
reXects a steric constraint imposed by the 7-methyl group that aVects the conformational change in the binding pocket as a result of reti-
nal photoisomerization. Transducin activation is reduced, when compared to the native pigment with 11-cis-retinal. Molecular dynamics
simulations suggest coupling of the C7 methyl group and the -ionone ring with Met207 in transmembrane helix 5 in agreement with
recent experimental results.
© 2006 Elsevier Ltd. All rights reserved.
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The visual pigment rhodopsin (Rho), the prototypical
G-protein-coupled receptor (GPCR) (Hargrave, 2001;
Menon, Han, & Sakmar, 2001), is a 40 kDa protein consist-
ing of 348 amino acids folded into seven transmembrane
-helices interconnected by hydrophilic extramembranous
loops. Its chromophore, 11-cis-retinal (Fig. 1), is covalently
bound as an inverse agonist at the -amino group of Lys296
(helix 7) via a protonated SchiV base, the counterion of
which is Glu113 (helix 3).
Visual transduction, the process by which visual cells con-
vert light into a neural signal transmitted to the brain along
the optic nerve, is triggered by the absorption of a photon by
the chromophore 11-cis-retinal. The photochemically
induced isomerization to all-trans-retinal and subsequent
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doi:10.1016/j.visres.2006.07.031thermal relaxation of the pigment through a series of inter-
mediates leads to the agonist-bound state termed metarho-
dopsin II (Meta II, max D380 nm), with an unprotonated
SchiV base. At this stage, the interaction of the extramembra-
nous loops on the cytoplasmic side with transducin (Gt), a
member of the G-protein superfamily, activates the enzy-
matic cascade leading to visual transduction. Hydrolysis of
105 molecules of cGMP to GMP, inactivation of Meta II by
phosphorylation with rhodopsin kinase, closing of the cat-
ion-speciWc channels in the rod outer segment of visual cells
and build up of electric potential, results in generation of the
neural signal providing the sensation of vision (Stryer, 1991;
Sakmar, Franke, & Khorana, 1989; Rando, 2001; McBee,
Palczewski, Baehr, & Pepperberg, 2001).
The 11-cis-retinal chromophore is exquisitely designed
to occupy the binding site of rhodopsin acting as an inverse
agonist, and thus to abrogate its activity. This is most likely
due to its distorted conformation around the C6–C7 and
C12–C13 bonds because of the steric interactions between
C5–CH3/H8 and C13–CH3/H10. Being adapted to the
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an absolute sense of twist that aVects the absorption max-
ima of the visual pigments and the movements of the chro-
mophore after the initial photoisomerization.
There is an ongoing debate regarding the movements of
the chromophore following the 11-cis to trans photoisomer-
ization in Rho, in particular whether a ring Xip of the C6–C7-
s-cis to the C6–C7-s-trans conformation occurs and its eVect
in the activation step of the visual process (Albeck et al.,
1989; Jang et al., 2001). Photocross-linking experiments by
Nakanishi using (11Z)-3-diazo-4-oxo[15-3H]retinal sug-
gested a Xip-over of the ionone ring in the Batho to Lumi
transition (Fishkin, Berova, & Nakanishi, 2004), which
appears to be consistent with computations (Ishiguro, 2000).
However, solid-state 13C NMR observations are compatible
with intermediates retaining the chromophore in its original
location in Rho up to the active Meta II state (Spooner et al.,
2002; Spooner et al., 2003; Spooner et al., 2004).
The C6–C7 bond of retinal in native Rho was recently
established to be in the s-conformation through binding
studies of two enantiomeric 6-s-cis-locked analogues (R)-3
and (S)-3 (Fujimoto et al., 2001; Fujimoto et al., 2002). On
the other hand, the 2.8 Å resolution X-ray structure (Teller,
Okada, Behnke, Palczewski, & Stenkamp, 2001) indicates
that the C12–C13-s-bond helicity is most likely positive
(Chan, Nakanishi, Ebrey, & Honig, 1974; Rando, 1996), in
keeping with recent theoretical analysis (Buss, Kolster, Ter-
stegen, & Vahrenhorst, 1998; Buss, 2001), thus correcting ear-
lier estimations of negative helicity (Kakitani, Kakitani, &
Yomosa, 1977; Han & Smith, 1995; Lou, Hashimoto, Ber-
ova, & Nakanishi, 1997; Lou et al., 1999).
ArtiWcial visual pigments, generated by treatment of the
apoprotein opsin with synthetic analogues of retinal (Nak-
anishi & Crouch, 1995), in particular when combined with
mutations of opsin, have been invaluable in the study of the
role that conformational changes of the chromophore play
in the visual cycle. We have recently reported the conse-
quences of sterically perturbing the C6–C7-conformational
equilibrium by incorporating methyl groups at the C8 posi-
tion (Alvarez, Domínguez, Pazos, Sussman, & de Lera,
2003) (Fig. 1), with the Wnding that the perturbation
extends to the C9-C10 bond, thus impairing reconstitution.
It was considered that the methyl group at the C7 position
could hinder the C6–C7 free rotation due to steric interac-
tions with C1-2CH3, thus becoming the non-lockedanalogue of bicyclic systems, and allowing the examination
of a region of the chromophore which has been shown pre-
viously to be important for the stability of early rhodopsin
photointermediates (Randall et al., 1991; Lewis, Pinkas,
Sheves, Ottolenghi, & Kliger, 1995).
We have now synthesized 11-cis-7-methylretinal (Fig. 1)
and studied chromophore regeneration in binding experi-
ments with native and mutated opsins. We Wnd that opsin
can be regenerated with the 7-methyl analogue (7-methyl-
Rho) to a similar extent as with native 11-cis-retinal (Rho)
and forms a chromophore that is blue-shifted to 490nm. The
spectroscopic properties of the dark-state of 7-methyl-Rho
are similar to those of Rho except for a slightly lower thermal
stability of the protein. In constrast, the photobleaching
behaviour is clearly altered indicating an eVect of the methyl
group at C7 in the photoactivation pathway of rhodopsin.
Molecular modelling studies suggest that this methyl group is
in the vicinity of Met207 in transmembrane helix 5 of rho-
dopsin. Accordingly, this part of the retinal molecule, partic-
ularly the -ionone ring, would come in close contact with
Met207 after illumination in agreement with recent theoreti-
cal (Saam, Tajkhorshid, Hayashi, & Schulten, 2002) and
experimental NMR studies (Crocker et al., 2006).
Our results, taken together with previous studies on other
retinal analogues, reinforce the current model of rhodopsin
function, where photoactivation is very eVectively controlled
by the tight molecular coupling between opsin and 11-cis-
retinal. 11-cis-Retinal is a unique molecule with a chemical
design that allows optimal interaction with the opsin apo-
protein in its binding pocket, and this is essential for the for-
mation of the light-activated conformation of the receptor.
2. Materials and methods
2.1. Stereoselective synthesis of 11-cis-7-methylretinal
The synthetic scheme we developed, for the synthesis of retinoids, is
based on the direct attachment of the side-chain precursor to the hydro-
phobic ring using the Suzuki cross-coupling reaction of functionalyzed
fragments (Dominguez, 2005), and will be described in detail elsewhere.
2.2. Protein expression, regeneration, and characterization
2.2.1. PuriWcation of rhodopsin from ROS
ROS membranes, prepared by an ultracentrifugation method and
using previously described conditions (del Valle, Ramon, Cañavate,
Dias, & Garriga, 2003) were solubilized in buVer B (1.8 mM KH2PO4,Fig. 1. 11-cis-8-Methylretinal and 11-cis-7-methylretinal chemical structures. The 8-methyl derivative was previously studied (Alvarez et al., 2003). The 7-
methyl analogue of 11-cis-retinal used in the present study has been newly synthesized.
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passed through a Sepharose column that has the monoclonal Rho 1D4
antibody covalently attached. Rhodopsin bound to the antibody column
is washed with buVer A (1.8 mM KH2PO4, 10 mM NaHPO4, 137 mM
NaCl, 2.7 mM KCl, pH 7.2) and eluted in buVer C (2 mM Na2HPO4, pH
6, +0.05% DM) containing 100 M of a 9-mer corresponding to the last
nine amino acids of the C-terminal tail of rhodopsin (TETSQVAPA).
2.2.2. Expression and puriWcation of recombinant wild-type (wt) and mutant 
rhodopsin
Wt and mutant opsin genes were expressed in transiently transfected
monkey kidney cells (COS-1) as described (Oprian, Molday, Kaufman, &
Khorana, 1989). After the addition of 20 M 11-cis-retinal or 11-cis-7-
methylretinal in the dark, the transfected COS-1 cells were solubilized in
1% DM, and the proteins were puriWed by immunoaYnity chromatogra-
phy using the Rho-1D4 monoclonal antibody (Oprian et al., 1989).
2.2.3. UV–vis absorption spectra of wt and mutant rhodopsin
UV–visible absorption spectra were performed with a Cary 100Bio Var-
ian spectrophotometer equipped with water-jacketed cuvette holders con-
nected to a circulating water bath with a Peltier accessory at 20 °C. All
spectra were recorded with a bandwidth of 2 nm, a response time of 1 s, and
a scan speed of 240 nm/min. Baseline correction was performed with buVer
C (Na2HPO4 2 mM, pH 6, +0.05% DM) in 150 L quartz cuvettes and all
experiments were carried out in a dark room under complete darkness or
under dim red light using Kodak No2 Wlters (12.7–17.8 cm). For photo-
bleaching experiments samples were illuminated with a Dollan–Jenner 150-
W Wber optic light (Fiber-lite MI-150) equipped with a >495-nm long-pass
Wlter for 10 s, and the corresponding spectra were recorded immediately
after illumination. The hydroxylamine reactivity of wt and mutant rhodop-
sins in the dark was followed as a decay of the absorption visible band in
the dark in the presence of 30 mM hydroxylamine. Thermal bleaching of
rhodopsin was determined by following the decay of the visible chromo-
phoric band in the dark at 55 °C as a function of time. In the case of pig-
ment regeneration experiments, a rhodopsin/retinal 1:2 molar ratio was
used. Retinal was added to puriWed rhodopsin and spectra were recorded
after illumination for 10 s in a time course experiment. Regeneration exper-
iments were followed by recording spectra every 5 min in the cycle mode of
the spectrophotometer. In the acidiWcation experiments, samples were acid-
iWed by addition of 1% concentrated H2SO4 solution (1.5 L to a total of
150 L) and spectra were recorded 30 s after acidiWcation.
2.2.4. Gt activation assay
Gt was prepared from bovine rod outer segments as described (Ting,
Goldin, & Ho, 1994). Gt activation was measured by means of Xuorescence
spectroscopy. The Xuorescence technique has been previously applied to
the study of rhodopsin mutants (Fahmy & Sakmar, 1993; Jager et al.,
1994; Farrens, Altenbach, Yang, Hubbell, & Khorana, 1996). Fluorescence
measurements were carried out with an Aminco SL spectroXuorometer
with excitation and emission wavelengths of 295nm (2-nm slit width) and
340 nm (16-nm slit width), respectively. BrieXy, rhodopsin (40 nM) was
added to a continuously stirred solution of Gt (250 nM) and GTPS
(5 M) in 10 mM Tris–HCl, pH 7.4, 100 mM NaCl, 2 mM MgCl2, and
0.012% DM. The reaction was initiated by illuminating the sample for 30 s
with a 150 W-Wbre optic light source through a 495-nm cut-oV Wlter. The
assay was carried out at a temperature of 20 °C. The relative initial rates of
Gt activation were obtained from the slope of the Xuorescence increase in
the Wrst 60 s after illumination and normalised to the value obtained for wt
rhodopsin (Rho) taken as 1.00.
2.3. Molecular modelling
2.3.1. Rhodopsin structure and embedding into virtual lipid model
The rhodopsin model was built based on recent crystal structures (Li,
Edwards, Burghammer, Villa, & Schertler, 2004; Okada et al., 2002). All
amino acids were considered in the protonated state as they exhibit as
free amino acids in water at pH 7, with the exception of Asp83 and
Glu122, which were treated as protonated and neutral in accordancewith experimental evidence (Fahmy et al., 1993). Protein embedding in
the bilayer was performed by placing the protein in a box containing a
mixture of DPPC lipids, water molecules and ions generated and equili-
brated according to a procedure described previously (Lindahl &
Edholm, 2000). After the protein was placed in the center of the box, all
ions and water molecules with the oxygen atoms closer than 0.40 nm to
any non-hydrogen atom of the protein and all lipid molecules with at
least one atom closer than 0.25 nm were removed. The resulting Wnal sys-
tem contained 195 lipids, 15,782 water molecules, 56 sodium, and 56
chloride ions.
2.3.2. Molecular dynamics (MD) simulations
All computer simulations were performed using the GROMACS 3.2
package (Berendsen, Vanderspoel, & Vandrunen, 1995; Lindahl, Hess, & van
der Spoel, 2001). The system was subjected to periodic boundary conditions
in the three coordinate directions. The temperature was kept constant at
323 K and the pressure was kept at 0.1 MPa in the three coordinate directions
by independent barostats. All bonds of the protein and lipid molecules were
kept frozen using the LINCS algorithm (Miyamoto & Kollman, 1992). The
bonds and the angle of the water molecules were Wxed using the analytical
SETTLE method. The equations of motion were integrated using the leap-
frog algorithm with a time step of 2 fs. Lennard–Jones interactions were com-
puted with a cutoV of 1.0 nm and the electrostatic interactions were treated
with the Particle Mesh Ewald (PME) technique (Darden, York, & Pedersen,
1993). The all-atom OPLS force Weld (Jorgensen, Maxwell, & TiradoRives,
1996) currently implemented in GROMACS was used for all molecules of the
system, except for the DPPC molecules that were modeled using the force
Weld parameters described previously (Berger, Edholm, & Jahnig, 1997). The
procedure used for running the MD simulations is described below. Once
rhodopsin was inserted in the bilayer, the system was energy minimized. Sub-
sequently, the system was subjected to a 0.5 ns MD simulation to allow for the
removal of voids present between the protein and the lipids or water, being
the atomic coordinates of the protein restrained to their crystallographic posi-
tions. After that, a 10 ns simulation of rhodopsin with 11-cis-retinal in the
dark-state was performed. Starting from the snapshot obtained after running
4 ns of the preceding simulation, the structure of 11-cis-retinal was modiWed
to that of 11-cis-7-methylretinal and a subsequent 10 ns simulation was per-
formed with the methylated derivative. Additionally, two more simulations
were performed changing the torsion potential around the C11–C12 bond
abruptly in both systems containing either 11-cis-retinal or 11-cis-7-methylre-
tinal in order to force the isomerization from the 11-cis to all-trans conWgura-
tion of the chromophore. These simulations were performed starting from the
structures obtained after running 1 ns of the corresponding simulations with
the 11-cis isomers. For all the simulations, coordinates were collected every
10 ps and stored for further analysis.
3. Results and discussion
3.1. ROS rhodopsin regeneration with 11-cis-7-methylretinal
Rhodopsin, puriWed from bovine retinal rod outer seg-
ments (ROS) by immunoaYnity chromatography, was
regenerated with 11-cis-7-methylretinal (7-methyl-Rho)
(Fig. 2). The 11-cis-retinal analogue was added to the puri-
Wed rhodopsin in dodecyl maltoside (DM) detergent solu-
tion and the sample was subsequently illuminated. Spectra
of the regeneration process were recorded in a time course
experiment (Fig. 2, inset). The initial spectrum in the dark
shows the typical absorbance bands at 280 and 500 nm cor-
responding to native rhodopsin (with 11-cis-retinal, Rho)
and a band at 376 nm corresponding to the free 11-cis-7-
methylretinal added to the sample. After 10 s illumination
with light of > 495 nm, rhodopsin was bleached and the
chromophore band at 500 nm was converted to a species
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mination—the last one recorded after illumination—shows
clear regeneration of the chromophoric band in the visible
region in the vicinity of 500 nm. A small but deWnite
blue-shift of the visible band to 490 nm can be detected.
3.2. Expression and characterization of 7-methyl-Rho
WT protein expressed in transiently transfected COS-1
cells and puriWed by immunoaYnity chromatography was
regenerated with 11-cis-retinal (Rho) and 11-cis-7-meth-
Fig. 2. Chromophore regeneration of puriWed rhodopsin from native ROS
in DM detergent solution (buVer C). UV–vis absorption spectrum of dark
ground-state rhodopsin regenerated with 11-cis-7-methylretinal plus free
added 11-cis-7-methylretinal (—). Absorption spectrum of the rhodopsin
sample after illumination for 10 s with light of  > 495 nm (- -). Absorption
spectrum of the sample 2 h after illumination showing the regenerated vis-
ible chromophoric band (,). Temperature, 20 °C. (Inset) time course of
the regeneration process of puriWed ROS rhodopsin with 11-cis-7-meth-
ylretinal.ylretinal (7-methyl-Rho). The UV–vis absorption spectra in
the dark, after illumination and acidiWcation for these pro-
teins are shown in Fig. 3. The 7-methy-Rho formed normal
chromophore and UV–visible absorption spectra in the
dark with a max at 490 nm and a A280/A490 1.8, the same as
the A280/A500 of Rho indicating that the binding pocket is
formed and able to accommodate the retinal analogue. This
result is in agreement with what was observed in the case of
the ROS rhodopsin regenerated sample (Fig. 2). The regen-
eration experiments indicate that, after incubation of opsin
with 11-cis-7-methylretinal (max D 368 nm in MeOH),
regeneration is observed with both native ROS and with
puriWed recombinant wt rhodopsin, and the chromophoric
yield is similar to that of 11-cis-retinal.
After 10 s illumination of 7-methyl-Rho, with light of
> 495 nm, the visible band at 490 nm was not fully con-
verted to Meta II species with maximum at 380 nm, but
rather two bands of similar intensity are detected at 373
and 467 nm, respectively (Fig. 3B), indicating that the
methyl group introduced at C7 in retinal causes a stability
change in photointermediates. AcidiWcation of the sample
after illumination resulted in formation of a band with max
at 427 nm with concomitant decrease in the bands at 373
and 467 nm. This indicates that the two bands, at 373 and
467 nm, correspond to species that are covalently linked to
opsin through an unprotonated and protonated SchiV base
linkage, respectively. An altered photobleaching behavior
has been previously observed for rhodopsin mutants in the
transmembrane domain and mutations associated with the
degenerative disease of the eye retinitis pigmentosa, like
G51V and G89D (Hwa, Garriga, Liu, & Khorana, 1997;
Bosch, Ramon, del Valle, & Garriga, 2003). A similar alter-
ation in the native photointermediate pathway formationFig. 3. UV–visible absorption spectra in the dark in buVer C (dark), after illumination for 10 s with light of  > 495 nm, and acid denaturation (acid).
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with other retinal analogues, like an acyclic retinal (Bartl
et al., 2005) or polyene methylated retinals (Vogel et al.,
2006).
Rho did not show hydroxylamine reactivity in the dark,
indicating that hydroxylamine could not access the SchiV
base linkage, and this reXects that the protein has a compact
structure in the dark. A similar result was obtained for 7-
methyl-Rho suggesting that 7-methyl-Rho has a compact
structure around the SchiV base linkage like Rho. Thermal
stability at 55 °C of 7-methyl-Rho in the dark was reduced
(t1/2 D 4.6 min, Rho t1/2 D 13.1 min), indicating that the dark-
state was less stable when the protein is regenerated with the
methylated analogue (Fig. 4). Spectra of the regeneration
process were recorded in a time course experiment for Rho
and 7-methyl-Rho and the total regeneration and regenera-
tion kinetics of both proteins were similar (data not shown).
Further illumination of 7-methyl-Rho for 1 or 5 min
only caused a small decrease in the 467 nm band with a con-
comitant slight increase in the 373 nm band (Fig. 5A). The
altered photointermediate with max at 467 nm decayed
with time to a species with max at 485 nm (Fig. 5B). The
Wgure shows representative spectra at diVerent times after
illumination and the diVerence spectrum between those at
Fig. 4. Dark-state stability at 55 °C of Rho () and 7-methyl-Rho ()
determined by measuring the decay of the absorbance band at 500 and
490 nm, respectively.
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560 and 0 min (Fig. 5B, inset). It is interesting to note that
two diVerent Meta I photointermediates, Meta Ia and Meta
Ib have been recently proposed to absorb at 485 and
465 nm, respectively (Shichida & Morizumi, 2006), very
close to the absorbances observed in our experiments
(Fig. 5B). In our case, the altered photointermediate path-
way is a consequence of a methyl group introduced at the
C7 position of 11-cis-retinal, causing a stability change in
activation photointermediates.
We have also analyzed the E134Q mutant—Glu134
belongs to the D(E)RY triplet which is highly conserved
through the GPCR superfamily—which mimics the pro-
tonated state in photo-activated rhodopsin and which
facilitates the Meta II conformation (Vogel et al., 2006;
Bartl et al., 2005; Fahmy, Sakmar, & Siebert, 2000). The
UV–vis spectrum after illumination of E134Q mutant
regenerated with 11-cis-7-methylretinal (7-methyl-E134Q)
(490 nm band in the dark) showed two bands, one at
373 nm and the other at 485 nm. In this case, the E134Q
mutation, in contrast to the results reported with other
retinal structures (Bartl et al., 2005), could not facilitate
light-induced Meta II formation (no shift of the proton-
ated species at 485–380 nm was detected) (Fig 3C and D).
A summary of the data for the dark, light, and acidiWed
spectra of WT Rho and the mutant E134Q is depicted in
Table 1.
In order to elucidate if the diVerent species formed in the
light activation process are in equilibrium, 100M of the
high aYnity peptide Gt-HAA (VLEDLKSCGLF) was
Table 1
max of the absorption bands in the UV–vis absorption spectra of rhodop-
sin proteins in the dark, and after illumination and acidiWcation
a In the case of the 7-methyl-containing pigments, and because of the
blue-shift observed for the visible band, the A280/A490 ratio is used.
Recombinant 
protein
max (dark) 
(nm)
max (light) 
(nm)
max (acid) 
(nm)
A280/A500
a
Rho 500 380 440 1.8
7-Methyl-Rho 490 373/467 427 1.8
E134Q 500 380 440 1.6
7-Methyl-E134Q 490 373/485 435 1.6Fig. 5. Photobleaching and decay of the 467-nm species at a temperature of 20 °C. (A) The photobleaching of 7-methyl-Rho was further explored by illu-
minating the sample for diVerent time periods after the Wrst initial 10 s illumination as indicated in the Wgure. (B). The band formed after 10 s illumination
was allowed to decay in the dark at 20 °C. The band decayed to form a new band at 485 nm as shown in the Wgure where representative spectral time
points are depicted. The presence of an isosbestic point indicates a change between two distinct conformational states. The diVerence between the initial
illuminated spectrum (after 10 s illumination) and that after 120 min shows a maximum at about 500 nm and a minimum at about 450 nm (inset).
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mann, 2000). No change in band formation or intensity
could be appreciated after illumination of 7-methyl-Rho in
the presence of the Gt-HAA peptide (Fig. 6). Illumination
of 7-methyl-E134Q in the presence of Gt-HAA peptide
shifted most of the 485 nm band to 373 nm. Higher concen-
tration of peptide (1 mM Gt-HAA) was required to shift
most of the protonated band of 7-methyl-Rho to 373 nm
(Fig. 6D). This suggests that the species formed after illumi-
nation of pigments regenerated with 11-cis-7-methylretinal
are in equilibrium and that this equilibrium is shifted with
the Gt-HAA peptide to the 373-nm species.
3.3. G protein activation
The functionality of 7-methyl-Rho and E134Q-7-methyl-
Rho was also determined by measuring the transducin acti-
vation by means of a Xuorescence assay which monitors
intrinsic tryptophan Xuorescence changes in the G protein
resulting from GTPS uptake. The initial rates of activation
for 7-methyl-Rho and 7-methyl-E134Q are similar to those
of the same proteins regenerated with the native 11-cis-reti-
nal chromophore (Table 2). However, the total level of acti-
vation for the methylated proteins was reduced to about
half of that of Rho. This result suggests that one of the two
species formed (373nm or 467 nm band with similar intensi-
ties) is responsible for the total Gt activation observed while
the other species is not active. A Wrst interpretation could be
that the 373 nm corresponds to the active species and that
the 467 nm band corresponds to an inactive Meta I-like spe-
cies. However, it is tempting to speculate that the 373nm canbe an inactive unprotonated SchiV base linked species—typ-
ically active Meta II conformation absorbs at 380 nm—
while the 467 nm band could correspond to a protonated
SchiV base linked species that may be active. There are pre-
vious reports of protonated SchiV base species capable of
transducin activation, like G90D congenital night blindness
mutant (Rao, Cohen, & Oprian, 1994; Fahmy, Zvyaga, Sak-
mar, & Siebert, 1996). Further experiments are required to
clarify this point. It is also possible that the decreased ability
to activate Gt of the methylated protein is due to a faster
rate of Meta II decay for the sample as has been experimen-
tally observed (data not shown).
3.4. Molecular modelling
MD simulations were carried out to get further insight
into the understanding of the experimental results
Table 2
Gt activation measured, by a Xuorescence assay as described in Section 2,
of wt Rho and the E134Q mutant regenerated with 11-cis-retinal and with
the 7-methyl analogue
a Relative total Gt activation measured as the maximal Xuorescence
increase.
b Initial activation rates derived from the Wrst 60 s of the Xuorescence
curves.
Recombinant 
protein
Relative total 
Gt activation
a
Relative initial 
activation rateb
Rho 1.00 1.00
E134Q 0.95 0.95
7-Methyl-Rho 0.55 0.91
7-Methyl-E134Q 0.50 0.85Fig. 6. UV–visible absorption spectra in the dark in buVer C (dark), after illumination for 10 s with light of  > 495 nm, and acid denaturation (acid) of
Rho, 7-methyl-Rho and 7-methyl-E134Q in the presence of diVerent concentrations of the high aYnity peptide Gt-HAA (VLEDLKSCGLF), a peptide
of the C-terminal domain of the -subunit of Gt. (A) Rho with 100 M Gt-HAA; (B) 7-methyl-Rho with 100 M Gt-HAA; (C) 7-methyl-E134Q with
100 M Gt-HAA; and (D) 7-methyl-Rho with 1 mM Gt-HAA. The spectra were recorded at a temperature of 20 °C.
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4478 L. Bosch et al. / Vision Research 46 (2006) 4472–4481obtained. To this aim, four models of the retinal binding
sites for both Rho and 7-methyl-Rho, with the retinal in
the 11-cis and the all-trans conWgurations, respectively,
were obtained (Fig. 7). These models were extracted from a
set of MD simulations of rhodopsin in the dark-state and
after the isomerization of the retinal from the 11-cis to the
all-trans conWguration. Despite that these simulations do
not lead to the active state of rhodopsin (the time-scale
required for such a calculation is still beyond the current
possibilities of atomistic MD simulations), they can be use-
ful in order to give insight into the understanding of the
activation process. The isomerization was performed using
a procedure similar to that previously described (Lemaitre,
Yeagle, & Watts, 2005; Rohrig, Guidoni, & Rothlisberger,
2002; Saam et al., 2002).
The analysis of these MD simulations suggests that the
methylation at position C7 not only introduces an addi-
tional steric volume in the cavity, but also modulates sig-
niWcantly the conformation of the -ionone ring relative to
the polyene chain. Indeed, when comparing the simulations
corresponding to Rho and 7-methyl-Rho we observe, in
both the dark-state and the isomerized from, that the orien-
tation of the -ionone ring relative to the polyene chain
changes from a more co-planar conformation in the case of
Rho to an almost perpendicular conformation in the case
of 7-methyl-Rho. This diVerence is associated with the ste-
ric repulsion between the methyl group adjacent to C7 and
the methyl groups in the -ionone ring.In the dark-state, both retinal and residues forming the
binding site exhibit subtle diVerences when comparing the
MD simulations of Rho and 7-methyl-Rho (Fig. 7, top pan-
els). Accordingly, the -ionone in Rho is located in a pocket
between residues Trp265, Phe212, Glu122, Leu125, and
Met207. Interestingly, retinal occupies the space available
because of the absence of side-chain in Gly121. These Wndings
are in agreement with the available crystallographic structures
of rhodopsin in the dark-state (Li et al., 2004; Okada et al.,
2002; Okada et al., 2004; Palczewski et al., 2000). Moreover,
no diVerences are detected in the conformations observed
depending on the retinal form used from the -carbon of
Lys296 up to the C8 of the covalently bonded retinal. The
existence of a methyl group adjacent to position C7 has a
direct inXuence on Met207, and on Glu122 to a lesser extent.
This is an interesting observation since Met207 has recently
been found to interact with the  -ionone ring in the Meta II
intermediate (Patel et al., 2004). However, the change in the
orientation of the -ionone ring induces additional changes in
the residues around the ring which are mostly hydrophobic.
Residues whose side-chains are moved or re-oriented more
signiWcantly are Leu125, Phe212, Trp265, and Glu122. In all
cases the diVerences observed are subtle and in agreement
with the Wndings that the retinal binding site can accommo-
date the retinal analogue similarly to the native 11-cis-retinal
chromophore.
After isomerization, the “L”-type shape which the
11-trans retinal adopts is far diVerent from the “U”-typeFig. 7. Model of the rhodopsin binding pocket for either retinal or 7-methylretinal extracted from MD simulations (see Section 2). The top panels
correspond to opsin with retinals in the 11-cis form and the bottom panels to opsin with retinals isomerized to 11-trans.
L. Bosch et al. / Vision Research 46 (2006) 4472–4481 4479shape that characterizes the 11-cis conWguration. This new
“L”-type shape can no longer allow the -ionone ring to be
accommodated within the pocket formed by residues
Trp265, Phe212, Leu125, and Glu122. In this way, the ring
is forced to occupy other sub-pockets. Interestingly, the
simulations performed with both Rho and 7-methyl-Rho in
the all-trans conWguration suggest a diVerent localization of
the -ionone ring due to the conformational peculiarities of
the methylated analogue. In Rho, the -ionone ring inter-
acts, after isomerization, with the hydrophobic residues
Phe208, Phe212, Tyr191, and Met207, whereas in the
7-methyl-Rho the -ionone ring interacts with Glu122,
Cys167, His211, Thr118, Ile189, and Met207. Trp265 is in
all cases moved apart from the -ionone ring and becomes
closer to the polyene chain. This is in accordance with a
recent experimental study which proposed that the interac-
tion of Trp265 with the retinal chromophore is responsible
for stabilizing the inactive conformation in the dark, and
that the motion of the -ionone ring allows Trp265 and
transmembrane helix H6 to adopt the active conformations
upon illumination (Crocker et al., 2006). Moreover, it is
important to highlight that the main diVerence between
Rho and 7-methyl-Rho is that the -ionone ring is located
in opposite sides around Met207, suggesting the impor-
tance of the methylation at position C7 in the conforma-
tions achieved after the isomerization. Regarding the
interactions of the methyl group at C7 in the methylated
chromophore, in the dark-state the methyl group lies close
to Glu122 and Met207, whereas after isomerization it
becomes closer to Thr118 maintaining the interactions with
Met207 (Fig. 7, bottom panels).
SigniWcant changes regarding the orientations of the C19
and C20-methyl groups can be observed after retinal isomer-
ization, not only because of the diVerent conWguration of the
double bond itself, but also due to the diVerent localization
of the -ionone ring that leads to a rearrangement of neigh-
boring side-chains interacting with the polyene chain in both
Rho and 7-methyl-Rho. Thus, the C20-methyl group inter-
acts with Ala295 in the dark-state in all cases, and with
Ala292 after isomerization. Positions of the C20-methyl
group are similar in Rho and 7-methyl-Rho. That is not the
case of the C19-methyl group which adopts an slightly diVer-
ent orientation, being closer to Thr118 in the case of Rho.
The C19-methyl group, which is interacting with Ile189 and
Thr118 in the dark in both Rho and 7-methyl-Rho is moved
towards Ty268 and Tyr191, occupying the space between
them after isomerization. Another aromatic residue, Tyr268,
exhibits a signiWcant displacement due to the existence of
both the C19 and C20-methyl groups pointing to the same
side. This displacement is larger in the case of Rho because of
the diVerent location of the -ionone ring.
3.5. Role of Met207 in the conformational change upon 
rhodopsin activation
The methyl group at C7 is positioned close to Met207 in
transmembrane helix 5 of rhodopsin (Fig. 7). Interestingly,Met207 has been proposed to come in close contact with
the -ionone of the retinal in the activated Meta II state
both by molecular dynamics (Saam et al., 2002) and NMR
studies (Crocker et al., 2006). In our case the observed
altered photobleaching behaviour could be reXecting the
steric constraint imposed by the added methyl group at C7.
This methyl group is likely aVecting the conformational
change in the protein induced by the cis–trans isomeriza-
tion of the retinal chromophore, and could be partially
blocking the transition to the active Meta II conformation.
This would result in a decreased Gt activation, as experi-
mentally observed (see Table 2). Evidence of the important
role of the -ionone ring and its methyl groups in rhodop-
sin photoactivation, particularly in the Meta I–Meta II
transition, has been obtained by using retinals with ring
modiWcations in a recent FTIR study (Vogel, Siebert,
Lüdeke, Hirshfeld, & Sheves, 2005).
Amino acid residues at the equivalent position of
Met207 in rhodopsin, like Ser203 in the -adrenergic recep-
tor generally have strong propensities to mediate helix or
ligand interactions (Liu, Eilers, Patel, & Smith, 2004; Patel
et al., 2005). For instance, in the H2-histamine receptor, this
position is occupied by an Asp that has been suggested to
interact electrostatically with the positively charged hista-
mine ligand (Birdsall, 1991). In addition, Met207 causes
ADRP when mutated to Arg in the Met207Arg mutant
(Farrar et al., 1992) and patients with this mutation show a
severe clinical phenotype. It was recently found in a theo-
retical study that Met207Arg mutant has an altered pattern
of light absorption based on quantum mechanical simula-
tions (Padron-Garcia et al., 2004) but no molecular evalua-
tion of the mutation has been reported so far.
We are currently constructing mutants at Met207 (the
RP mutant Met207Arg and others) to further dissect the
role of this residue in the coupling of opsin to the retinal
and in the activation process. The speciWc study of
Met207Arg mutation can provide new insights into the
molecular defects associated with retinitis pigmentosa
mutations in rhodopsin. Further work is also in progress
to increase the size of the alkyl group at C7 that could
hinder the rotation of the C6–C7 bond and thus aVect the
structural and functional behaviour of the native pig-
ment. The combined study of Met207 mutants and other
retinal analogues with bulkier substitutions at C7 should
add relevant information to the unravelling of the
detailed mechanism of the rhodopsin photoactivation
process.
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